Acute coronary syndrome: Pharmacotherapy

Prehospital Emergency Care

Volumn 5, Issue 1, 2001, Pages 58-64

  O'Connor, Robert ^a   Persse, David ^b   Zachariah, Brian ^c   Ornato, Joseph P ^d   Swor, Robert A ^e   Falk, Jay ^f   Slovis, Corey M ^g   Storrow, Alan B ^h   Griswell, John K ⁱ  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Los Colinas Medical Center   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WILLIAM BEAUMONT HOSPITAL   (United States)

^f ORLANDO REGIONAL MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁱ Medstar Ambulance and Emergency Physicians Advisory Board   (United States)

Author keywords

Acute coronary syndrome; Antiplatelet agents; Cardiac diseases; Drugs; Emergency medical services; Fibrinolysis; Pharmacotherapy; Prehospital treatment

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANISTREPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; ESMOLOL; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; NITRATE; RETEPLASE; STREPTOKINASE; TIROFIBAN;

ACUTE HEART FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; ELECTROCARDIOGRAM; HOSPITAL CARE; HUMAN; HUMAN TISSUE; LONG TERM CARE; META ANALYSIS; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 0035187406     PISSN: 10903127     EISSN: None     Source Type: Journal    
DOI: 10.1080/10903120190940353     Document Type: Conference Paper

References (43)

1. Guidelines for the Management of Patients with Acute Myocardial Infarction
2. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: A nationwide perspective of current clinical practice
3. Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995-1996
4. Randomized trial of intravenous strep-tokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
5. Platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrillin therapy. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
6. Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease
7. Design and methodology of the PURSUIT trial: Evaluating eptifibatide for acute ischemic coronary syndrome
8. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators Dose ranging trial of enoxaparin for unstable angina: Results of TIMI 11A
9. ESSENCE trial results: Breaking new ground: Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events
10. Low-molecular weight heparins in non-ST-segment elevation ischemia: The ESSENCE trial. Efficacy and safety of subcutaneous enoxaparin versus intra venous unfractionated heparin, in non-Q-wave coronary events
11. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1
12. Metoprolol in Acute Myocardial Infarction patient population
13. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial
14. Safety of prehospital therapy with morphine sulfate
15. A comparison of metoprolol and morphine in the treatment of chest pains in patients with suspected acute myocardial infarction - The MEMO study
16. Effect of intravenous metroprolol before hospital admission on chest pain in suspected acute myocardial infarction
17. Prehospital-initiated vs hospital-initiated thrombolytic therapy
18. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications, and long-term results in 529 patients
19. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
20. Prehospital management of acute myocardial infarction in an experimental metropolitan system of medical emergencies
21. Early and predischarge aspirin administration among patients with acute myocardial infarction: Current clinical practice and trends in the United States
22. Prevalence of aspirin use among patients calling 9-1-1 for chest pain
23. Education of paramedics regarding aspirin use
24. Prehospital administration of aspirin in patients with unstable angina and acute myocardial infarction
25. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
26. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
27. Myocardial Infarction Triage and Intervention Project - Phase I: Patient characteristics and feasibility of prehospital initiation of thrombolytic therapy
28. A randomized trial of propranolol in patients with acute myocardial infarction I Mortality results
29. Effect on mortality of metoprolol in acute myocardial infarction: A doubleblind randomized trial
30. Beta blockade during and after myocardial infarction: An overview of randomized trials
31. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction (TIMI) II-B Study
32. Impact of asthma therapy on cardiovascular disorders in the elderly
33. Atrial arrhythmias
34. Adjunctive drug therapy of acute myocardial infarction - Evidence from clinical trials
35. Emergency management of atrial fibrillation and flutter: Intravenous diltiazem versus intravenous digoxin
36. A randomized, double-blind com parison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery
37. Treatment of myocardial infarction in the United States (1990-1993): Observations from the National Registry of Myocardial Infarction
38. Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomized trials
39. Safety of prehospital nitroglycerin
40. Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration
41. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnei sium sulphate in 58,050 patients with suspected acute myocardial infarction
42. General hospital management